Administrative Guidance against PMDA(医薬品医療機器総合機構)

PMDA(医薬品医療機器総合機構) (Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical Devices)
Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical DevicesMinistry of Health, Labour and WelfareAugust 27, 2021

Action summary

Company
Original: PMDA(医薬品医療機器総合機構)
Governing law
Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical Devices
薬機法
Action type
Administrative Guidance
行政指導
Action date
August 27, 2021
Issuing authority
Ministry of Health, Labour and Welfare
厚生労働省

Violation

Machine-translated summary — verify against original

Explanation of the number of approvals and review periods for items related to COVID-19 measures, promotion of early practical use of program medical devices, full implementation of MDSAP, and revisions to the electronic application system.

Show original Japanese text

新型コロナウイルス感染症対策に関する品目の承認件数や審査期間の状況、プログラム医療機器の早期実用化促進、MDSAPの本格施行、電子申請システムの改修等についての説明。

Source

Original Ministry of Health, Labour and Welfare announcement (in Japanese)

The original Japanese disclosure is the authoritative record.

Watch this company

Get an email when PMDA(医薬品医療機器総合機構) has new enforcement actions or registry changes (representative, address, business status). Sign-in is via a one-time email link — no password.

Company info

English name
PMDA(医薬品医療機器総合機構) Japanese only
Japanese name
PMDA(医薬品医療機器総合機構)
See company profile →

About this recordAggregated and translated from public Japanese government disclosures. The English text is for reference only — authoritative content is the linked Japanese source.